Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,050.00
Bid: 12,038.00
Ask: 12,040.00
Change: -106.00 (-0.87%)
Spread: 2.00 (0.017%)
Open: 12,092.00
High: 12,178.00
Low: 12,010.00
Prev. Close: 12,156.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UPDATE 2-FTSE 100 recovers 1% on energy, healthcare stock boost; Entain jumps

Tue, 21st Sep 2021 09:14

(For a Reuters live blog on U.S., UK and European stock
markets, click LIVE/ or type LIVE/ in a news window)

* Kingfisher top FTSE 100 loser despite positive results

* Royal Dutch Shell sells U.S. oilfield assets

* Stagecoast surges on merger talks with rival

* FTSE 100 up 1.0%, FTSE 250 adds 0.8%
(Updates to close)

By Shashank Nayar

Sept 21 (Reuters) - London's FTSE 100 rebounded on Tuesday,
aided by gains in energy and healthcare stocks, and Entain
jumped to the top of the index after the Ladbrokes owner said it
received an offer from DraftKings.

The blue-chip FTSE 100 ended 1.0% higher and
recorded its best session in two months. Oil major BP and
Royal Dutch Shell were among the top boosts.

Entain jumped 18.0%, leading gains on travel and
leisure stocks, after it confirmed that U.S.
fantasy sports betting company DraftKings has made an
offer to buy the British gambling firm in a deal that one media
report said could be valued at $20 billion.

The FTSE 100 has gained 8% so far this year on support from
dovish central bank policies and re-opening optimism. However,
higher inflation pressures have raised scepticism among
investors that central banks might hint later this week towards
pulling back massive asset purchases sooner than expected.

"Investors are still progressing ahead with fingers crossed
as the Fed and the BoE are unlikely to declare any tapering
measures this time, as it would potentially unsettle the global
equity environment before the third-quarter earnings season,"
said Kunal Sawhney, chief executive at Kalkine.

Healthcare stocks gained 1.5% with drugmakers
including AstraZeneca, Indivior, Oxford
BioMedica up between 1.6% and 4.8%.

The domestically focussed mid-cap index rose 0.8%,
with travel stocks being among the top gainers.

In earnings-driven moves, Kingfisher fell 4.9% to
the bottom of the FTSE 100 even as the British home improvement
retailer reported a jump in first-half profit.

Royal Dutch Shell jumped 3.6% after it said it would sell
its Permian Basin assets to ConocoPhillips for $9.5
billion in cash, exiting the largest U.S. oilfield.

British transport company Stagecoach Group surged
27.0% to the top of mid-cap index, after it said it was in talks
with rival operator National Express about a possible
all-share merger. National Express was up 7.6%.

Semiconductor technology company Alphawave jumped
19.4% on raising its 2021 guidance after reporting a 140% rise
in first-half revenue.
(Reporting by Shashank Nayar and Amal S in Bengaluru; Editing
by Saumyadeb Chakrabarty, Subhranshu Sahu and Marguerita Choy)

More News
3 May 2024 12:17

CORRECT: Angle shares up on assay development deal with AstraZeneca

(Correcting company name in headline)

Read more
3 May 2024 11:50

Angle shares up on assay development deal with AstraZenaca

(Alliance News) - Shares in Angle PLC jumped on Friday, after the company said it has been chosen to develop a prostate cancer assay using its Parsortix technology, opening the door for future clinical study-supporting contracts.

Read more
3 May 2024 07:50

LONDON BRIEFING: InterContinental Hotels makes first-quarter progress

(Alliance News) - London's FTSE 100 is called to open higher on Friday, on the expectation of a softer US jobs report, which could take some sting out of hawkish Federal Reserve interest rate expectations.

Read more
2 May 2024 10:04

AstraZeneca notes positive trial results for Calquence treatment

(Alliance News) - AstraZeneca PLC on Thursday said it observed positive high-level results in the Echo phase 3 trial of its Calquence treatment for previously untreated adult patients with mantle cell lymphoma.

Read more
2 May 2024 07:45

AstraZeneca reports positive results from blood cancer drug trial

(Sharecast News) - AstraZeneca has reported positive results from the use of its Calquence drug in a clinical trial to treat a rare type of blood cancer.

Read more
29 Apr 2024 22:52

J&J, Bristol Myers lose challenges to US drug price negotiation program

April 29 (Reuters) - A U.S. judge on Monday rejected a challenge by Bristol Myers Squibb and Johnson & Johnson to a law requiring them to negotiate the prices of their blockbuster blood clot prevention drugs with the U.S government's Medicare health insurance program or pay heavy penalties.

Read more
29 Apr 2024 10:02

LONDON BROKER RATINGS: Deutsche Bank likes Frasers; Barclays cuts JD

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

Read more
29 Apr 2024 09:13

AstraZeneca makes progress with Truqap and Enhertu cancer treatments

(Alliance News) - AstraZeneca PLC on Monday said its Truqap drug has been recommended for approval in the EU to treat a form of breast cancer, while also noting trial results for its Enhertu offering.

Read more
29 Apr 2024 07:50

LONDON BRIEFING: Hipgnosis Songs Fund backs new Blackstone bid

(Alliance News) - London's FTSE 100 is called to open higher on Monday, with heady gains for US tech stocks on Friday brightening the mood in Europe and Asia at the start of the new week.

Read more
29 Apr 2024 07:24

AstraZeneca makes progress with two breast cancer treatments

(Sharecast News) - AstraZeneca issued favourable updates on two of its breast cancer treatments on Monday - 'Truqap', or capivasertib, and 'Enhertu', or trastuzumab deruxtecan - following encouraging results from respective phase three trials.

Read more
26 Apr 2024 09:33

LONDON BROKER RATINGS: Peel Hunt cuts ConvaTec to 'reduce'

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning:

Read more
25 Apr 2024 16:57

LONDON MARKET CLOSE: FTSE 100 shakes off red-hot US inflation gauge

(Alliance News) - London's FTSE 100 outperformed on Thursday, enjoying a solid rise on largely well-received corporate earnings and a share price jump for miner Anglo American after it received a takeover bid from peer BHP.

Read more
25 Apr 2024 15:14

London close: Stocks finish mixed as US GDP growth slows

(Sharecast News) - London's stock markets finished with a mixed performance on Thursday, as investors digested a slower-than-expected GDP growth reading from the United States, while a slew of well-received earnings underpinned the top-flight index.

Read more
25 Apr 2024 11:50

LONDON MARKET MIDDAY: FTSE 100 hits high on offer for Anglo American

(Alliance News) - The FTSE 100 was outperforming European markets at midday on Thursday, with the index boosted to a record high thanks to takeover talks.

Read more
25 Apr 2024 10:33

AstraZeneca leaps after smashing first-quarter forecasts

Q1 revenue up 19% to $12.68 bln

*

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.